Clostridium difficile Colitis in Children with Cystic Fibrosis

Digestive Diseases and Sciences

Volumn 49, Issue 1, 2004, Pages 116-121

  Hussain, Sunny Zaheed ^a   Chu, Cathy ^b   Greenberg, David P ^a   Orenstein, David ^a   Khan, Seema ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

C. difficile; Children; Colitis; Cystic fibrosis

Indexed keywords

LINEZOLID; METRONIDAZOLE; TOBRAMYCIN; VANCOMYCIN;

ADOLESCENT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; COLITIS; CYSTIC FIBROSIS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; HUMAN; ISOLATION AND PURIFICATION; LABORATORY TEST; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; RADIOGRAPHY; SYMPTOM; THROMBOCYTE TRANSFUSION; TOMOGRAPHY; TREATMENT OUTCOME;

ADOLESCENT; CLOSTRIDIUM DIFFICILE; CYSTIC FIBROSIS; DIAGNOSIS, DIFFERENTIAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; MALE; TOMOGRAPHY, X-RAY COMPUTED; VANCOMYCIN;

EID: 0842313176     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000011612.74033.78     Document Type: Article

References (51)

1. Rivlin J, Lerner A, Augarten A, Wilschanski M, Kerem E, Ephros MA: Severe Clostridium difficile-associated colitis in young patients with cystic fibrosis. J. Pediatr 132:177-179, 1998
2. Winesett DE, Rhoads JM, Boat TF: Pseudomembranous colitis in a patient with cystic fibrosis. J Pediatr Gastroenterol Nutr 18:244-246, 1994
3. Hall IC, O'Toole E: Intestinal flora in newborn infants with a description of a new pathogenic anaerobe: Bacillus difficilis. Am J Dis Child 49:390-402, 1935
4. Klinger PJ, Metzger PP, Seelig MH, Pettit PD, Knudsen JM, Alvarez S: Clostridium difficile infection: Risk factors, medical and surgical management. Dig Dis 18:147-60, 2000
5. Kelly CP, LaMont JT: Clostridium difficile infection. Annu Rev 49:375-390, 1998
6. Mylonakis E, Ryan ET, Caldwerwood SB: Clostridium difficile-associated diarrhea. Arch Intern Med 161:525-531, 2001
7. Bartlett JG: Antibiotic associated diarrhea. Clin Infect Dis 15:573-581, 1992
8. Wu TC, McCarthy VP, Gill VP: Isolation rate and toxigenic potential of Clostridium difficile isolates from patients with cystic fibrosis. J Infect Dis 148:176, 1983
9. Tedesco FJ, Anderson CB, Ballinger WF: Drug-induced colitis mimicking an acute surgical condition of the abdomen. Arch Surg 110:481-484, 1975
10. Meyers S, Mayer L, Bottone E, Desmond E, Janowitz HD: Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology 80:697-700, 1981
11. Fainstein V, Bodey GP, Fekety R: Relapsing pseudomembranous colitis associated with cancer chemotherapy. J Infect Dis 143:865, 1981
12. Peach SL, Borriello SP, Gaya H, Barclay FE, Welch AR: Asymptomatic carriage of Clostridium difficile in patients with cystic fibrosis. J Clin Pathol 39:1013-1018, 1986
13. Peach SL, Borriello SP, Gaya H: Carriage of Clostridium difficile in patients with cystic fibrosis and control group. J Med Microbiol 18:5, 1984
14. Welkon CJ, Long SS, Thompson M Jr, Gilligan PH: Clostridium difficile in patients with cystic fibrosis. Am J Dis Child 139:805-808, 1985
15. Sherertz RJ, Sarubbi FA: The prevalence of Clostridium difficile and toxin in a nursery population: A comparison between patients with necrotizing enterocolitis and an asymptomatic group. J Pediatr 100:435-439, 1982
16. Pokorny CS, Bye PTP, Macleod C, Selby WS: Antibiotic-associated colitis and cystic fibrosis. Dig Dis Sci 37:1464-1468, 1992
17. Barbero GJ, Schwachman H, Grand R, et al.: Gastrointestinal and nutritional manifestations of cystic fibrosis. In Cystic Fibrosis: Projections into the Future. Mangos JA, Talamo RC (eds). Miami, Symposia Specialists, 1976, pp 83-111
18. Rolfe RD, Helebian S, Finegold SM: Bacterial interference between Clostridium difficile and normal fecal flora. J Infect Dis 143:470-475, 1981
19. Wilson KH, Silva J, Fekety R: Suppression of Clostridium difficile by normal hamster cecal flora and prevention of antibiotic-associated cecitis. Infect Immun 34:626-628, 1981
20. Catagliuolo I, Valenick L, Riegler M, LaMont JT, Pothoulakis C: Oligosaccharide containing sialic acid and N-acetyl-glycosamine mediate Clostridium difficile toxin B(TxB) binding and biological effects in human colonic mucosa. Gastroenterology 114:A949 (abstr G3889), 1998
21. Viscidi R, Laughon BE, Yolken R, Bo-Linn P, Moench T, Ryder RW, Bartlett JG: Serum antibody response to toxins A and B of Clostridium difficile. J Infect Dis 148:93-100, 1983
22. Aoronsson B, Granstrom M, Mollby R, Nord CE: Serum antibody response to Clostridium difficile toxins in patients with Clostridium difficile diarrhea. Infection 13:97-101, 1985
23. Warny M, Vaerman JP, Avesani V, Delmee M: Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun 62:384-389, 1994
24. Kyne L, Warny M, Qamar A, Kelly CP: Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 342:390-397, 2000
25. Leung DY, Kelly CP, Boguniewicz M, Pothoulakis C, LaMont JT, Flores A: Treatment with intravenously administered gamma globulins of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 118:633-637, 1991
26. Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, Simmons RL: Fulminant Clostridium difficile: an under-appreciated and increasing cause of death and complications. Ann Surg 235:363-372, 2002
27. Putterman C, Rubinow A: Reactive arthritis associated with Clostridium difficile associated pseudomembranous colitis. Semin Arthritis Rheum 22:420-426, 1993
28. Binkovitz LA, Allen E, Bloom D, Long F, Hammond S, Buonomo C, Donnelly LF: Atypical presentation of Clostridium difficile colitis in patients with cystic fibrosis. Am J Roentgenol 172:517-521, 1999
29. Fang FC, Madinger NE: Clostridium difficile colitis. N Engl J Med 330:1754, 1994
30. Talbot RW, Walker RC, Bean RW Jr.: Changing epidemiology, diagnosis and treatment of Clostridium difficile toxin-associated colitis. Br J Surg 73:457-460, 1986
31. Tedesco FJ, Corless JK, Brownstein RE: Rectal sparing in antibiotic-associated pseudomembranous colitis. A prospective study. Gastroenterology 77:295-297, 1979
32. Burbige EJ, Radigan JJ: Antibiotic associated colitis normal appearing rectum. Dis Colon Rectum 24:198-200, 1981
33. Pickhardt PJ, Yagan N, Siegel MJ, Balfe DM, Rothbaum RJ: Cystic fibrosis: CT findings of colonic disease. Radiology 206:725-730, 1998
34. Fishman EK, Kavuru M, Jones B: Pseudomembranous colitis: CT evaluation of 26 cases. Radiology 180:57-60, 1991
35. Merine D, Fishman EK, Jones B: Pseudomembranous colitis: CT evaluation. J Comput Assist Tomogr 11:1017-1020, 1987
36. Goodman PC, Federle MP: Pseudomembranous colitis. J Comput Assist Tomogr 4:403-404, 1980
37. Yankes JR, Baker MD, Cooper C, Garbutt J: CT appearance of focal pseudomembranous colitis. J Comput Assist Tomogr 12:394-396, 1988
38. Hamrick KM, Tishler JM, Schwartz ML, Koslin DB, Han SY: The CT findings in pseudomembranous colitis. Comput Med Imaging Graph 13:343-346, 1989
39. Schmitt-Grohe S, Wiggen E, Steffan J, Handke R, Zielen S: Severe antibiotic-associated colitis in a patient with cystic fibrosis and colonic wall thickening. J Pediatr Gastroenterol Nutr 34:224-226, 2002
40. Johnson S, Homann SR, Bettin KM, Quick JN, Clabots CR, Peterson LR, Gerding DN: Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole: a randomized, placebo-controlled study. Ann Intern Med 117:297-302, 1992
41. Teasley DG, Gerding DN, Olson MM, Peterson LR, Gebhard RL, Schwartz MJ, Lee JT Jr.: Prospective randomized trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhea and colitis. Lancet 2:1043-1046, 1983
42. Moyenuddin M, Williamson JC, Ohl CA: Clostridium difficile-associated diarrhea: Current strategies for diagnosis and therapy. Curr Gastroenterol Rep 4:279-286, 2002
43. Bartlett JG: Treatment of Clostridium difficile colitis. Gastroenterology 89:1192-1195, 1985
44. Saginur R, Hawley CR, Bartlett JG: Colitis associated with metronidazole therapy. J Infect Dis 141:772-774, 1980
45. Thomson G, Clark AH, Hare K, Spilg WGS: Pseudomembranous colitis after treatment with metronidazole. Br Med J 282:864-865, 1981
46. Guerrant RL, Gilder TV, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, Hennessy T, Griffin PM, Du Pont H, Sack RB, Tarr P, Neill M, Nachamkin I, Reller LB, Osterholm MT, Bennish ML, Pickering LK: Infectious Diseases Society of America: Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 32:331-351, 2001
47. Kyne L, Kelly CP: Recurrent Clostridium difficile diarrhea. Gut 49:152-153, 2001
48. Pochapin M: The effect of probiotic on Clostridium difficile diarrhea. Am J Gastroenterol 95:S11-S13, 2000
49. Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Belle G: Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study. Gastroenterology 96:981-988, 1989
50. Gorbach SL, Chang TW, Goldin B: Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 2:1519, 1987
51. Rifkin GD, Fekety FR, Silva J Jr: Antibiotic-induced colitis implication of a toxin neutralized by Closiridium Sordelli Anti-Toxin. Lancet 11:1103-1106, 1977